BARDA and Department of the Air Force’s Acquisition COVID-19 Task Force (DAF ACT) Awards $53.7 Million Contract to Ortho Clinical Diagnostics


WEB ANNOUNCEMENT
About Image

BARDA in coordination with Department of the Air Force’s Acquisition COVID-19 Task Force (DAF ACT) has awarded an undefinitized contract action (UCA) to Ortho Clinical Diagnostics.  This UCA will lead to a firm fixed price commercial contract of $53.7 million supporting the COVID-19 response and will increase production capacity of U.S. COVID-19 antibody and antigen test kit assays as well as test analyzers.

The industrial base expansion effort, with a planned final value of $53.7 million, will allow Ortho Clinical Diagnostics to order long lead equipment to establish a domestic production capability of VITROS Systems and SARS-CoV-2 Antigen and Antibody Tests at its Rochester, New York Global Center of Excellence facility for R&D.

At the completion of this expansion effort, Ortho Clinical Diagnostics will increase its production capacity from 1.8 million tests per month to 6.7 million tests per month by April 2022.

The DOD’s Defense Assisted Acquisition (DA2) Cell led this effort in coordination with the Department of the Air Force’s Acquisition COVID-19 Task Force (DAF ACT). BARDA funded this contract through the Health Care Enhancement Act (HCEA) to enable and support domestic industrial base expansion for critical medical resources.

Last Updated: April 01, 2021

BARDA’s COVID-19 Domestic Manufacturing & Infrastructure Investments

BARDA strategic partnerships fostering and expanding Pharmaceutical Manufacturing in America by increasing U.S.-based manufacturing capacity to produce active pharmaceutical ingredients and generic medicines needed during the COVID-19 response, and during future public health emergencies; visit BARDA’s COVID-19 Domestic Manufacturing & Infrastructure Investments to learn more.

Website Refresh - www.medicalcountermeasures.gov is pleased to announce a phased launch of our newly redesigned public website. We are making website improvements to provide a more modern and customer-centric web experience. Over the next several months you will see differences throughout the site while we continue implementing updates. Thank you for your understanding and please let us know if you have any questions: techwatchinbox@hhs.gov